Literature DB >> 8194803

Glomerular hyperfiltration and serum beta 2-microglobulin used as early markers in diagnosis of autosomal dominant polycystic kidney disease.

D Dimitrakov1, E Kumchev, E Lyutakova, L Grigorov.   

Abstract

This study was undertaken to investigate the dynamics of glomerular filtration and serum beta 2-microglobulin in patients with confirmed autosomal dominant polycystic kidney disease (ADPKD) without chronic renal failure (CRF). Twenty five patients (11 women and 14 men, age range 15 to 56 years) with echographically and computer-tomographically proven ADPKD were entered into the study. Glomerular filtration was followed using the 24 hour creatinine clearance and beta 2-microglobulin serum level was measured radioimmunologically using an ABBOTT laboratories kit. 12 patients had a significantly reduced glomerular filtration: 1.01 +/- 0.05 ml/s compared with 2.12 +/- 0.15 ml/l in the control group (P < 0.001). This group of patients also had a significantly increased level of the serum beta 2-microglobulin: 3.54 +/- 0.47 micrograms/l versus 1.42 +/- 0.28 micrograms/l in healthy controls (P < 0.001). Seven of the patients showed normal glomerular filtration and significantly increased beta 2-microglobulin: 2.65 +/- 0.46 micrograms/l (P < 0.05). The glomerular filtration in six of the patients was found to be significantly increased (hyperfiltration) 2.65 +/- 0.04 ml/s (P < 0.001) while their serum beta 2-microglobulin level tended to rise (2.25 +/- 0.3 micrograms/l). We believe that glomerular hyperfiltration combined with the increased level of the serum beta 2-microglobulin can be used as an early marker of ADPKD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8194803

Source DB:  PubMed          Journal:  Folia Med (Plovdiv)        ISSN: 0204-8043


  6 in total

Review 1.  Glomerular hyperfiltration: definitions, mechanisms and clinical implications.

Authors:  Imed Helal; Godela M Fick-Brosnahan; Berenice Reed-Gitomer; Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2012-02-21       Impact factor: 28.314

2.  Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease.

Authors:  Imed Helal; Berenice Reed; Kim McFann; Xiang-Dong Yan; Godela M Fick-Brosnahan; Melissa Cadnapaphornchai; Robert W Schrier
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-08       Impact factor: 8.237

3.  Early renal abnormalities in autosomal dominant polycystic kidney disease.

Authors:  Esther Meijer; Mieneke Rook; Hilde Tent; Gerjan Navis; Eric J van der Jagt; Paul E de Jong; Ron T Gansevoort
Journal:  Clin J Am Soc Nephrol       Date:  2010-04-22       Impact factor: 8.237

4.  Prospective change in renal volume and function in children with ADPKD.

Authors:  Melissa A Cadnapaphornchai; Kim McFann; John D Strain; Amirali Masoumi; Robert W Schrier
Journal:  Clin J Am Soc Nephrol       Date:  2009-04       Impact factor: 8.237

5.  Kidney Function Reserve Capacity in Early and Later Stage Autosomal Dominant Polycystic Kidney Disease.

Authors:  A Lianne Messchendorp; Marco van Londen; Jacob M Taylor; Martin H de Borst; Gerjan Navis; Niek F Casteleijn; Carlo A J M Gaillard; Stephan J L Bakker; Ron T Gansevoort
Journal:  Clin J Am Soc Nephrol       Date:  2018-09-25       Impact factor: 8.237

6.  Urine Fetuin-A is a biomarker of autosomal dominant polycystic kidney disease progression.

Authors:  Nathalie Piazzon; Florian Bernet; Linda Guihard; Wouter N Leonhard; Séverine Urfer; Dmitri Firsov; Hassib Chehade; Bruno Vogt; Sophia Piergiovanni; Dorien J M Peters; Olivier Bonny; Daniel B Constam
Journal:  J Transl Med       Date:  2015-03-30       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.